Cold, Cough and Sore Throat Remedies Market value of a little more than US$ 5,000 Million by 2026

Seeking professional medical help for curing cold, cough or sore throat is become a rare practice, let alone getting admitted in a hospital. Prevalence of cold, cough & sore throat problems through the ages has made people more independent in terms of treating them. In the years to come, effective home remedies will continue to gain traction and people will be taking care of their cold or sore throat through such easy-to-treat remedies.

Future Market Insights’ latest report delivers such discernments that are expected to leave a considerable imprint on the global market for cold, cough & sore throat remedies. Based on the report, the global cold, cough & sore throat remedies market is presently valued at US$ 32.4 Bn, and is anticipated to incur sluggish growth at 3.2% CAGR to bring in just over US$ 45.4 Bn by the end of 2026. The report distinctly indicates that rising adoption of self-medication practices and effective home remedies is restraining the market’s overall growth.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-1292

In the report, titled “Cold, Cough and Sore Throat Remedies Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” affordability of OTC drugs, rising economic burden of respiratory diseases, availability of medications in variable dosages, and fast & instant relief delivered through such cold, cough & sore throat remedies are driving the market’s growth. Nevertheless, the demand for cold, cough & sore throat remedies is less likely to soar at a healthy rate.

Product Recalls & Low Entry of New Players Impacting the Market’s Growth

Firstly, the global cold, cough & sore throat remedies market is projected to witness umpteen product recalls. Global leaders in pharmaceuticals industry such as Novartis AG, Pfizer Inc., Bayer AG, GlaxoSmithKline plc., and Reckitt Benckiser Group plc are key players in the global market for cold, cough & sore throat remedies. Despite, there are several newly-launched products that have been recalled after FDA’s censure. Besides, even consumer goods behemoths such as Procter & Gamble Co. and Johnson & Johnson Services Inc. are partaking in the market’s growth. This has resulted in a lowering entry of emerging drugmakers, which has further distorted the market’s growth. Other leading manufacturers of cold, cough & sore throat remedies include AstraZeneca plc, Prestige Brands Inc., and Sun Pharmaceutical Industries Ltd.

The report highlights how Asia-Pacific excluding Japan (APEJ) region will remain the largest market for cold, cough & sore throat remedies. The region’s proximity to environmental pollution makes its residents more prone to respiratory diseases. With over 30% stake in global revenues, the APEJ cold, cough & sore throat remedies market will global dominate through 2026. North America and Europe will also remain at the forefront, by collectively accounting for nearly half of the global revenues throughout the forecast period.

The report further reveals that in 2017 and beyond, the demand for antihistamine drugs, expectorants and decongestants will remain considerably high as these revenues from sales of these drugs will showcase growth at more than 3% CAGR. Tablets or pills and nasal drops will also dominate as dosage types, accounting for over 40% share of market value through 2026. The report also predicts retail pharmacies & drug stores as the largest distribution channels for cold, cough & sore throat remedies. Together, these channels will bring in nearly US$ 30 Bn by the end of 2026.

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-1292

Key segments covered in this reportBy Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Drug Stores
  • Supermarket/ Hypermarkets
  •  e-Commerce/ Online pharmacies

By Dosage Type

  • Oral Syrup
  • Tablets/Pills
  • Lozenges
  • Nasal Drops
  • Others

By Drug Type

  • Antihistamines
  • Expectorants
  • Bronchodilators
  • Decongestants
  • Antibiotics
  • Others

Residue Hydrodesulphurization Catalyst Market Size, Top Key Players, Latest Trends, Regional Insights and Global Industry Dynamics By 2027

At present, the primary focus of the oil refiners is to convert the residues to produce stable LSFO i.e. low sulphur fuel oil and hydro-treated feedstock as per the market specification. With the increasing demand for secondary resources over the primary ones, the Residue Hydrodesulphurization Catalyst Market is expected to account for significant share over the forecast period. The residue hydrodesulphurization catalysts are traded mainly in the oil refineries depending upon the size distribution, pore size and activity grading.

The residue hydrodesulphurization catalyst market is estimated based on the operational activities in the oil refineries and petrochemical industries, where metals such as Nickel, Rhodium, Cobalt, Platinum and molybdenum are widely used for catalytic processes in order to reduce sulphur content to a desired level in the final product. This leads to a rise in demand for the residue hydrodesulphurization catalyst market. With the rising concern about air pollution caused by the combustion of gasoline products used in the transportation sector, the market for residue hydrodesulphurization will witness an exponential growth over the forecast period.

Request Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-4151

Residue Hydrodesulphurization Catalyst Market: Drivers and Restraints

Although the sulphur laden crude oil petroleum products have been treated since a longer period, the regulations proclaimed by the environment protection authorities have led to enforce major changes in the refining system to produce low sulphur fuel oil. In regions such as the U.S. and European nations, the government bodies have mandated deep hydrodesulphurization process to produce ultra-low sulphur diesel between the ranges of 300 to 500 ppm by weight of total sulphur. Such major steps adopted to limit environmental damages are expected to create lucrative growth in the residue hydrodesulphurization catalyst market in coming future.

Also, it has been observed that the deactivation rate has led to wastage of huge amount of catalyst, which results in reuse of the residue hydrodesulphurization catalyst. The disposal of such materials causes land pollution due to its toxic nature and creates landfill disposal problems. To overcome this, the solubilization process for metal extraction has been adopted to reuse the catalyst in a varied range of applications such as artificial mineral ores. Thus the residue hydrodesulphurization catalyst market is expected to gain opportunities, where spent catalysts are fed as raw material, since its demand over primary mineral resources is increasing.

Residue Hydrodesulphurization Catalyst Market: Region Wise Outlook

Based on the geography, the residue hydrodesulphurization catalyst market is expected to be prevalent in North America. The region is recognized for its oil refineries where residue hydrodesulphurization catalysts are expected to be in huge demand for the innovative technologies adopted in order to reduce the sulphur content in the crude oil by-products over the forecast period. The region is followed by the European nations where stringent regulations have to be followed to minimize air pollution.

The developing countries such as India and China, with the increasing demand for petroleum products due to significant developments in almost every sector, are expected to account for noteworthy monetary value for residue hydrodesulphurization catalyst market over the forecast period. The Middle East countries such as Kuwait with oil refineries in abundance are expected to account for substantial growth in residue hydrodesulphurization catalyst market over the forecast period.

Residue Hydrodesulphurization Catalyst Market: Market Participants

Some of the examples of recognized players in residue hydrodesulphurization catalyst market are listed below:

  • CRI Catalyst Company
  • Honeywell International Inc
  • China Petroleum & Chemical Corporation
  • China National Petroleum Corporation
  • BASF SE
  • Haldor Topsoe A/S
  • Albemarle Corporation
  • Axens
  • Johnson Matthey

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

For critical insights on this market, request to ask an expert here @ https://www.futuremarketinsights.com/ask-question/rep-gb-4151

Residue Hydrodesulphurization Catalyst Market: Segmentation

Residue hydrodesulphurization catalyst market can be segmented on the basis of product type:

  • Oxide Type
  • Sulfides Type
  • Transition Metal Type

Residue hydrodesulphurization catalyst market can be segmented on the basis of form:

  • Homogenous
  • Heterogeneous
  • Other

Residue hydrodesulphurization catalyst market can be segmented on the basis of application:

  • Petroleum Refining
  • Chemical Synthesis
  • Petrochemical Industry
  • Coal Chemical Industry

Contact Us –

Unit No: 1602-006

Jumeirah Bay 2

Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers Dubai

United Arab Emirates

LinkedIn| Twitter| Blogs

Companion Animal Vaccines Market is expected to grow at a CAGR of 6.9% over the forecast period and record sales worth U.S. $ 4.9 Billion by the end of 2028.

Remarkable increase in the companion animal ownership and strong growth of development of the veterinary healthcare infrastructure collectively push the sales of companion animal vaccines in global market. Surpassing the revenues worth US$ 2.5 Bn in 2021, global companion animal vaccines market is projected to exhibit a robust CAGR during 2022 – 2029. Measurable rise in the zoonotic disease prevalence will remain a key factor fueling the demand for companion animal vaccines and drugs.

FDA approvals for novel and innovative companion animal vaccines continue to present potential growth opportunities to R&D of companion animal vaccines. For instance, Zoetis received regulatory approval for ProHeart, used for prevention of heartworm diseases caused by Dirofilaria immitis in dogs.

Request Sample Copy of Report: https://www.futuremarketinsights.com/reports/sample/rep-gb-1427

Key Takeaways – Companion Animal Vaccines Market Study

  • Attenuated live vaccines currently account for more than a third of total market value, and will continue to witness a healthy CAGR through 2029. This demand growth is attributed to their improved effectivity and enhanced long-term preventive action.
  • North America is witnessing lucrative market growth compared to other regions attributed to increase in the adoption rate of companion animals, increase in veterinary healthcare expenditure, and increasing awareness about pet health.
  • Veterinary animal hospitals and clinics offering better service support for animal care are expected to  have  significant market share during the forecast period
  • As large number of people are in close contact with canine animals as a preference for companion animal, demand will be prominent among canine species.

Increasing R&D Investments to Widen Market Growth Prospects

Elanco, Ceva Sante Animale, Boehringer Ingelheim are among the leading market players in the companion animal vaccines market. These manufacturers continue to dominate the market landscape of companion animal vaccines by investing heavily in R&D activities to develop and launch therapeutic vaccines for prevention and treatment of various animal diseases. Surge in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the animal vaccines market growth.

For instance, in August 2018, Elanco invested two-thirds of the budget for food‐animal unit to develop vaccines and reduce the use of antibiotics. Moreover, rise in demand for animal vaccines led to the development of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 for prevention against infectious bronchitis virus (IBV) in animals.Know More About Companion Animal Vaccines Market Report

Future Market Insight brings the comprehensive research report on forecast revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2014 to 2029. The global companion animal vaccines is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights of the companion animal vaccines market on basis of product type (attenuated live vaccines, conjugated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, DNA vaccines, recombinant vaccines), species type (canine, avian, feline) and distribution channel (companion animal hospitals, companion animal hospitals, companion animal research institutes) across seven major regions.

Ask from the Market Research Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1427

 Segmented 

Product

  • Attenuated Live Vaccines
  • Conjugate Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • DNA Vaccines
  • Recombinant Vaccines

Species

  • Canine
  • Avian
  • Feline

Distribution Channel

  • Veterinary Clinics
  • Veterinary  Hospitals
  • Veterinary Research Institutes
  • Retail Pharmacies

Download PDF Brochure @ https://www.futuremarketinsights.com/reports/brochure/rep-gb-1427

Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • Japan
  • Middle East & Africa

Surgical Stapling Devices Market is expected to reach US$ 6.2 Billion by 2031

[195 Pages Report]  With deployment of advanced technologies, medical practitioners will keep adopting specialised devices that facilitate specific surgical operations in medical procedures. Rising number of invasive surgeries has necessitated the need for improved devices for wound management. And, surgical staples have effectively replaced sutures for closing wounds during such procedures.

Future Market Insights recently published its report on the global market for surgical stapling devices, the highlights from which indicate that rising number of laparoscopic surgeries performed across the globe have triggered the use of surgical stapling devices.

According to Future Market Insights, the global demand for surgical stapling devices is propelling along with the world’s rising geriatric population. Lesser time consumed by surgical stapling devices for closing wounds, and the accuracy & precision of these devices is favouring their adoption for treating wounds of aged patients. In 2016, close to US$ 2,000 Mn worth of surgical stapling devices were sold in the world. The report projects that these revenues will be doubled by the end of 2026, projecting that the global surgical stapling devices market will soar steadily at 7.6% CAGR.

In the report, titled “Surgical Stapling Devices Market: Global Industry Analysis and Opportunity Assessment, 2016-2026,” North America has been identified as the largest market for surgical stapling devices. By the end of forecast period, more than US$ 1,000 Mn revenues will be solely attributed by North America’s surgical stapling devices market.

Advanced healthcare infrastructure in Western Europe has facilitated the region’s surgical stapling devices market, which will register a value CAGR of 7.9% through 2026. Although, fastest consumption of surgical stapling devices will be witnessed in the Asia-Pacific excluding Japan (APEJ) region. The APEJ surgical stapling devices market is expected to soar at the highest CAGR of 8.6%. 

Leading Manufacturers of Surgical Stapling Devices:

  • Medtronic plc
  • Grena Ltd.
  • Purple Surgical Holdings Limited
  • Dextera Surgical Inc.
  • Johnson & Johnson Services, Inc.
  • 3M Company
  • Meril Life Sciences Pvt. Ltd.

The report reveals that hospitals will remain the largest end-users of surgical stapling devices in the world – accounting for more than 60% of global revenues. Meanwhile, the demand for surgical stapling devices will also gain traction in ambulatory surgical centres. Key findings in the report indicate that powered surgical stapling devices worth US$ 1,182 Mn were sold globally in 2016, while the demand for manual surgical stapling products is anticipated to incur a downtrend in the years to come.

Throughout the forecast period, six out of ten surgical stapling devices sold in the world are likely to be disposable, while revenues from reusable surgical stapling products will be growing at a sluggish rate. Preference to curved surgical stapling is also on a rise, revenues from which are expected to soar impressively at 9% CAGR.

surgical stapling devices market

Request a Sample Report with Table of Contents: http://www.futuremarketinsights.com/reports/sample/rep-gb-867

Dermatological surgeries will undoubtedly require greater number of surgical stapling devices. The report estimates that in 2016, nearly US$ 600 million revenues were amassed from the sales of surgical stapling devices in treatment of skin-related surgical wounds. The use of advanced surgical stapling devices is also expected to gain momentum for closing dissected or ruptured blood vessels during surgeries. Wounds situated in the patient’s digestive tract are also being treated by surgical stapling, and by the end of 2026, around US$ 665 million worth of devices will be consumed for such treatments.

We have segmented the global surgical stapling devices market into six sections. They are as follows: By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • MEA

By End User

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

By Stapling Type

  • Straight
  • Curved
  • Circular

By Usage Type

  • Disposable Surgical Stapling Devices
  • Reusable Surgical Stapling Devices

For More Information or Query or Customization Before Buying, Visit: https://www.futuremarketinsights.com/customization-available/rep-gb-867

By Indication

  • Skin
  • Digestive Tract
  • Blood Vessels
  • Hernia
  • Lungs
  • Others

By Product

  • Powered Surgical Stapling Devices
  • Manual Surgical Stapling Devices

Power Steering Fluids Market Current and Future Trends, Leading Players, Industry Segments and Regional Forecast By 2027

Power steering has a noteworthy impact on handling a vehicle, since it helps in turning the wheels easily using electric or hydraulic power or both. The power steering fluids play a very important role in safe driving due to the fact that oil is necessary for any engine for effective and continued operation. Without the use of power steering fluids, the power steering system would fail. Power Steering Fluids are hydraulic fluids, which are used for the transmission of power in the power steering assembly.The power steering fluids provide hydraulic assistance for the overall steering system. These fluids are made up of either synthetic oil or mineral oil blended with enhanced additives to prevent corrosion, supress foaming and to properly lubricate the steering gear and power steering pump. Lubricating agents are required in both hydraulic and electric steering.
The regular changing and servicing of the power steering fluids is important for every vehicle for the proper functioning as well as for the safety of the travellers in the vehicle. The services usually involve flushing out the old oil and then refilling with the new power steering fluid. Over the time, the O-rings, seals and the inner components of power steering wear out.When they break down, they spoil the power steering fluid, thus the power steering fluid pump has to work harder and it will finally lead to its failure. Therefore, the regular checking and replacing, if necessary, of the power steering fluid is a good practice, which will result in efficient working of the system. If there is a leakage in power steering system, it will not be easy for turning the vehicle with the actual force required. A leakage in the system can lead to accidents and hence immediate repair or replacement of the system has to be done.
To Remain ‘Ahead’ of Your Competitors, Request for A Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-4150
Power Steering Fluids Market: Dynamics
The numerous advantages of power steering fluids, as stated above, coupled with the ability to transfer the power so effectively are considered to be the prominent drivers for the global power steering fluids market. Moreover, the ease of taking long and hard turns with application of minimum power is expected to be a significant driver for the power steering market. The lifespan of the power steering system can be increased with the effective and regular use of power steering fluids. Analysing the aforementioned factors, the power steering fluids market is estimated to expand with an incremental rate in the near future. 

Power Steering Fluids Market: Regional Outlook

North America, Europe and the Middle East regions have abundant natural resources and manufacturing industries, which will drive the demand for power steering fluids in these regions. BRICS nations are expected to contribute significantly to the global power steering fluids market over the forecast period. Moreover, the need for transferring power into the power steering assembly, without any leakage or failure, at proper working and stable conditions is increasing day-by-day globally, which will fuel the growth of the global power steering fluids market.

The power steering fluidsmarket is projected to grow with a high CAGR over the forecast period, due to its increasing application in the automotive industry globally. Furthermore, new inventions and technologies in the power steering fluidssector will foster growth in the global market.

Power Steering Fluids Market: Market Participants

Some of the examples of market participants in the global power steering fluids market, identified across the value chain are,

  • AMSOIL INC.
  • The Armor All/STP Products Company
  • Lucas Oil Products, Inc.
  • BARDAHL
  • Red Line Synthetic Oil
  • Penrite Oil Company
  • ExxonMobil
  • CRP Industries Inc.
  • GM Dexron
  • Ford Motor Company
  • Valvoline
  • Recochem Inc.
  • Nulon Products Australia

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Ask Us Your Questions About This Report: https://www.futuremarketinsights.com/ask-question/rep-gb-4150

Power Steering Fluids Market: Segmentation

The power steering fluids market can be segmented on the basis of product type, material type, component and end use.By Product type, the Power Steering Fluids market can be segmented as:

  • Material Oil
  • Synthetic Oil

By Vehicle Type,the Power Steering Fluids market can be segmented as:

  • Passenger Car
  • LCVs
  • HCVs
  • Others

Contact Us –

Unit No: 1602-006

Jumeirah Bay 2

Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers Dubai

United Arab Emirates

LinkedIn| Twitter| Blogs

North America and Europe Artificial Pancreas Systems Market is projected to increase at a CAGR of 12.9% over the forecast period to reach more than US$ 250 Million by 2026

Growing number of diabetics in the US, Canada and European countries has been compelling hospitals to keep artificial pancreas systems in stock. Government-funded organisations in North America and Europe are collaborating with local as well as global medical device manufacturers to meet the rising demand for artificial pancreas systems. A latest report published by Future Market Insights reveals that the value of artificial pancreas systems market in North America and Europe reached US$ 86.5 Mn by the end of 2016. The report also predicts that people suffering from diabetes in these regions will keep opting for artificial pancreas systems in order to control their blood sugar levels externally.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/north-america-and-europe-artificial-pancreas-systems-market

Lifestyle of residents in Europe and North America is triggering the incidence of diabetes (type 1 as well as type 2) in these regions. Substantial rise in diabetic patients compels doctors, pathologists and endocrinologists to treat patients’ malfunctioning pancreas superficially. The rate at which a physiological pancreas get replaced with a substitute (artificial pancreas system) will keep gaining momentum in this region. By the end of 2026, more than US$ 280 Mn worth of artificial pancreas systems will be sold in North America and Europe, registering a revenue growth at 12.6% CAGR.

Almost every artificial pancreas system sold in these regions will treat patients suffering from type 1 diabetes. In US, the occurrence of diabetes mellitus type 1 is expected to surge beyond control. The US artificial pancreas systems market is presently valued at just over US$ 40 Mn, and will account for over two-third of North America’s artificial pancreas system revenues through 2026. Canada’s artificial pancreas system revenues, on the other hand, will surge rampantly at 13.8% CAGR.

Hospitals will remain the largest distribution channel for artificial pancreas systems across North America and Europe. Although, the report does highlight a noticeable presence of e-commerce websites in global distribution of medical devices as critical as artificial pancreas systems. Among these regions, North America will remain dominant over Europe’s artificial pancreas system market. Likewise, the demand for artificial pancreas systems will be fairly high in Western Europe, compared to Eastern Europe. Germany, France, the UK and Poland are leading European countries that are more likely to showcase revenue growth at over 11.5% CAGR.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-na-3058

One of the largest company in North America & Europe’s artificial pancreas systems market has been identified as Illinois-based medical device manufacturer – Medtronic plc. With it, the UK-based Cellnovo is also being recognised as a prominent manufacturer of artificial pancreas systems. Other key players in the artificial pancreas systems market across North America and Europe include, Johnson & Johnson Services, Inc., Dexcom Inc., Insulet Corporation, and Tandem Diabetes Care Inc.

North America and Europe artificial pancreas systems market: segmentationBy Region

  • North America
  • Western Europe
  • Eastern Europe

By Distribution Channel

  • Hospitals
  • E-Commerce

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-na-3058

By Disease Indication

  • Diabetes Type 1
  • Diabetes Type 2

Endovenous Laser Therapy Market is expected to reach US$ 811.0 Million by 2031

[151 Pages Report] According to a recent study by Future Market Insights (FMI), the global endovenous laser therapy market is expected to witness high growth during the forecast period. The market is expected to grow from US$ 378.3 Mn in 2021 to over US$ 811.1 Mn by 2031. This reflects a cumulative CAGR of around 7.9% over the forecast period (2022-2031).

Rise in number of varicose veins cases, availability of technologically advanced laser therapy, shift towards minimally invasive procedures and increasing product launches are the primary factors responsible for the growth of the market during the forecast period.

Varicose veins are more common in pregnant women, partially because the baby puts more pressure on the veins and partly because hormones generated during pregnancy relax vein walls. Varicose veins can develop as a result of damage to a deep leg vein. Over the projected period, rising instances of varicose veins are expected to drive revenue growth in the endovenous laser systems market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2785

Another factor that is having a positive impact on endovenous laser therapy is the rapid change in lifestyle with no physical activity and labour across the globe, as well as the rise in the elderly population, both of which are anticipated to contribute to the global market’s growth over the forecast period. The market is also expected to develop due to the quick and effective technique as well as the growing demand for endovenous laser therapy.Moreover, growing prevalence of obesity worldwide is driving growth of the endovenous laser therapy market. Obesity leads to problems related to blood circulation which leads to varicose veins.

Medical device manufacturers operating in the endovenous laser therapy market are focusing on providing user friendly devices to the end users to minimize chances of manual errors. In addition, continuous launch of new and improved products and increasing investment in research and development by the manufacturers in endovenous laser therapy devices would lead to growth of global market over the forecast period.

Key Takeaways from Endovenous Laser Therapy Market Study

  • Endovenous laser systems held the maximum share of 92.0% in 2021 by component, expanding at a rapid rate owing to the rising number of varicose veins cases and increase in number of product launches with advanced features.
  • Ambulatory surgical centers showed maximum growth among all end users with a market share of 36.2% in 2021 owing to the rise in demand for outpatient surgeries. In countries such as the U.S., endovenous laser therapy for varicose veins is majorly performed in ambulatory surgical centers rather than hospitals in order avoid long-time waiting in big hospital settings, which is why the segment is developing at a rapid rate
  • North America held the largest share of 42.7% of the global endovenous laser therapy market by region in 2021 indicating the growth due to increase in prevalence of obesity and growing number of FDA approvals in North America.

“Growing prevalence of varicose veins, shift towards minimally invasive procedures, availability of novel laser treatment and increasing number of product launches Is Expected to Drive the Demand for Endovenous Laser Therapy over the Decade,” says the FMI Analyst

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert – https://www.futuremarketinsights.com/ask-question/rep-gb-2785

Who is winning?The key market players covered by FMI include AngioDynamics, Inc., Syneron Medical Ltd., Dornier MedTech GmbH, Alma Lasers Ltd., Alna-Medical system GmbH, LSO Medical, Wontech Co., Ltd., intros Medical Laser GmbH and Energist Ltd.

Some of the leading manufacturers of endovenous laser therapy market are focusing on product launch, approvals, collaboration and partnership strategies for global expansion objectives, thereby, enhancing their market presence.

  • In January 2021, Syneron Medical Ltd. announced the availability of the Frax Pro™ system. The FDA-cleared and CE-marked, non-ablative fractional device is the first platform featuring dual-depth skin resurfacing with both Frax 1550™ and the novel Frax 1940™ applicators.
  • In July 2020, Wontech announced that ‘Picowon’, an alexandrite (755nm)-based pico laser, has obtained US Food and Drug Administration (FDA) approval for the first time in Asia and the second in the world.

Want more insights?Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global endovenous laser therapy market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.

The study provides compelling insights on endovenous laser therapy segment based on product (Endovenous Laser Systems {Diode Lasers and YAG Lasers}, and Endovenous laser Fibers {Bare Tip Laser Fiber, Radial Tip Laser Fiber and Gold Tip Laser Fiber}), and end user (hospitals, ambulatory surgical centers and Specialized Clinics) across seven major regions.

Endovenous laser therapy Market by CategoryBy Product

  • Endovenous Laser Systems
    • Diode Lasers
    • Yag Lasers
  • Endovenous Laser Fibers
    • Bare Tip Laser Fibers
    • Radial Tip Laser Fiber
    • Gold tip Laser Fiber

By End User

  • Hospitals
  • Ambulatory Surgical Centers
  • Specialized Clinics

For in-depth insights, Download a PDF Brochure – https://www.futuremarketinsights.com/reports/brochure/rep-gb-2785

By Region

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • APEJ
  • Japan
  • Middle East & Africa

Orthopaedic Imaging Equipment Market is expected to reach US$ 14.6 Billion by 2031

[174 Pages Report] According to a recent study by Future Market Insights (FMI), the global orthopedic imaging equipment market is expected reach US$ 9.8 Bn in 2021. Sales are expected to increase at a CAGR of around 4.0% over the forecast period (2021-2031).

Orthopedic imaging equipment is the medical imaging equipment used for bone scanning, implants scanning and is utilized for diagnosis purposes. Different imaging technologies such as X-rays, MRI, ultrasound, EOS and nuclear imaging are included in orthopedic imaging equipment.

Rising prevalence of orthopedic diseases and bone injuries, technological advancement in orthopedic imaging equipment devices, and rise in research and development activities by key manufacturers are factors driving the orthopedic imaging equipment market.

Numerous medical imaging modalities are currently enabling three-dimensional (3D) visualization with accuracy, and rapid diagnoses. Advancements in 3D imaging have led to development in computer-assisted detection (CAD) and image analysis applications. This is expected to boost the market for modality, primarily in tomographic imaging techniques.

orthopaedic imaging equipment market

For more insights into the market, request a sample of this report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1842

Moreover, surgeons are using 3D imaging to plan surgeries, which has led to increased application of these systems. This is expected to increase the utilization of imaging equipment, especially across the U.S. and the U.K.

Consequently, these devices are also gaining high traction in Asia such as China and India due to growing demand for better health care infrastructure. Improving healthcare infrastructure and technological developments in these countries will increase the demand for 3D medical imaging equipment.

Key Takeaways from Orthopedic Imaging Equipment Study

  • In terms of product type, the X-ray systems is expected to account for 28.0%, expanding at a CAGR of 3.3% during the forecasted period.
  • By indication, the acute injuries segment will contribute over 56.6% of sales in the global orthopedic imaging equipment market.
  • Hospitals and radiology centers will, collectively, account for 68.2% of the market share in 2021.
  • With the advancements in technologies as well as the increasing geriatric population, North America held the largest share of over 30.5% in 2021.
  • India and China are expected to lead the growth of South and East Asia in the global orthopedic imaging equipment market.

For any queries linked with the report, ask an analyst – https://www.futuremarketinsights.com/ask-question/rep-gb-1842

Who is winning?

The key market players covered by FMI include General Electric Healthcare Limited, Siemens AG, Esaote SPA, Hitachi Ltd, Koninklijke Philips N.V, PLANMED OY, EOS imaging, Canon Medical Systems Corporation, Carestream Health and Neusoft Corporation.

Some of the leading manufacturers of the orthopedic imaging equipment market are focusing on the development of advanced and cost-effective products establishing distribution agreements, collaborations and partnerships strategies for global expansion objectives, thereby, enhancing their market presence.

  • In September 2021, GE Healthcare acquired BK Medical for $1.45Bn to expand its $3bn ultrasound business from diagnostics to surgical and therapeutic interventions.
  • In April 2016, Hitachi Ltd Company integrated Hitachi Medical Corporation and Hitachi Aloka medical into Hitachi Ltd to strengthen its manufacturing operations and to develop low-cost medical devices.

Request a Complete TOC of this Report with figures:
https://www.futuremarketinsights.com/toc/rep-gb-1842

Want more insights?

Future Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2031. The global Orthopedic Imaging Equipment market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader. The study provides compelling insights on orthopedic imaging equipment segment based on Product (X-Ray System, CT-Scanner, MRI System, EOS Imaging Systems, Ultrasound, Nuclear Imaging Systems), Indication (Acute injuries {Sports injuries, Trauma cases}, Chronic Disorders { Osteoarthritis, Osteoporosis, Prolapsed Disc, Degenerative joint diseases} and Others), and End User (Hospitals, Radiology Centers, Emergency Care Facility, Ambulatory Surgical Center) across seven major regions.

Russia Viscosupplementation Market is projected to increase to over 68.8% by the end of 2026.

According to Future Market Insights’ recent report, titled “Viscosupplementation Market: Russia Industry Analysis and Opportunity Assessment, 2016-2026,” nearly 70% of viscosupplementation revenues amassed across Russia in 2016 were accounted by three-injection viscosupplementation. The report estimates that the Russian viscosupplementation market incurred revenues worth over RUB 1.13 billion (US$ 19 million) in 2016. Registering a steady increment at 5.8% CAGR, Russia’s viscosupplementation revenues are expected to reach RUB 2.02 billion (US$ 34 million) by the end of 2026. With higher demand for three-injection viscosupplementation, Russia’s healthcare industry leaders will continue to extend production of three-injection viscosupplementation products as opposed to single injection and five-injection viscosupplementation products.

Russia’s healthcare infrastructure will continue witnessing significant rise in number of orthopaedic patients as several bone & joint-related disorders are likely to be caused by people’s eating & drink habits, their proactive lifestyles and the country’s harsh weather conditions. Rising occurrence of joint-related ailments such as knee osteoarthritis in Russia are a result of people performing physical labour in severely cold weather conditions. This has necessitated the adoption of viscosupplementation as an ideal medical procedure for injecting lubricating fluid in bone joints during surgeries. An in-depth analysis of Russia’s viscosupplementation market, conducted by Future Market Insights, projects that demand for three-injection viscosupplementation will gain traction over the next decade.

The report also establishes projections regarding the end-use of viscosupplementation in Russia. Hospitals across the country will account for just above RUB 1.24 billion (US$ 21 million) revenues by the end of projection period. Within this, the demand for viscosupplementation will remain considerably higher in hospitals with capacity of more than 500 beds. End-use of viscosupplementation in Russia’s ambulatory surgical centres (ASCs) will remain nascent, while revenues accounted by orthopaedic clinics are expected to surpass RUB 595 million (US$ 10 million) through 2026.

Top Players in Russia’s Viscosupplementation Market

Top three established players in Russia’s Viscosupplementation market include Hyaltech, Croma-Pharma GmbH and TRB Chemedica. The market is fragmented with small players holding substantial market share. While Hyaltech, Croma-Pharma GmbH and TRB Chemedica collectively dominate with more than half of the country’s viscosupplementation revenues. International players such as Sanofi, Ferring Pharmaceuticals and Fidia Farmaceutici spa have low share as compared to the other players, Anika Therapeutics has recently launched their viscosupplementation product in Russia’s viscosupplementation market.

To remain ahead of your competitors, request for a sample – https://www.futuremarketinsights.com/reports/sample/rep-gb-2897

The market is divided into two segments based on product type and end use:By Product Type

  • Single Injection Viscosupplementation
  • Three Injection Viscosupplementation
  • Five Injection Viscosupplementation

By End Use

  • Hospitals
    • 500+ Bedded
    • 250-500 Bedded
    • Less Than 250 Bedded
  •  Ambulatory Surgical Centres
  • Orthopaedic Clinics

Cermet Market : Worldwide Industry Analysis and New Market Opportunities Explored By 2027

A Cermet is a material made by the combination of ceramic and metallic materials. Cermets are designed such that they poses optimum characteristics of both, metals and ceramics. They can be reshaped like metals and display high hardness and temperature resistance like ceramics. Cermets find applications as binders for borides, carbides or oxides. Usually, metallic materials or elements used for making cermets are cobalt, molybdenum and nickel. Cermets can also be metal matric compounds depending on their physical structure, but generally they have less than 20% metal by volume.
Cermets are used in the manufacturing of capacitors, resistors (especially potentiometer) and several other small electronic parts and components that are subjected to high temperatures. They are also used for cutting and material removing operations in saws and brazed tools, owing to their superior anti-corrosion and wear properties. Titanium carbide (TiC), Titanium carbonitride (TiCN), Titanium nitride (TiN) and other titanium materials, such as tungsten carbide can be formed if appropriately manufactured. Nevertheless, they need distinct handling during grinding operations.
Request a Sample of Rport – https://www.futuremarketinsights.com/reports/sample/rep-gb-4109
Cermets are increasingly finding varied applications in many manufacturing industries, due to their properties of malleability and ductility, typically associated with metals, alongside with favorable properties of ceramics, such as hardness and compressive strength. Cermet materials, such as aluminium-max phase compounds have important applications in aerospace and automotive industries. Particular categories of cermets are used as spacecraft shielding, since they possess properties to resist high velocity impacts from orbital debris and micrometeoroids much more successfully than custom spaceship materials, such as aluminum and other metals.Cermet Market: Dynamics

The cermet market has a lot of scope in the research and development department with innovative and advanced upgrades anticipated in the near future. Some prominent market participants are trying to develop advanced cermets that will possess ideal properties. The market has been evolving over a period of time and cermets have become an important material in aviation and space sectors. Growth of manufacturing industries by cutting and material removal operations with the use of cermets has boosted demand for the cermet market and hence, this market is forecasted to grow yet more rapidly in the future. The market for cermets will remain strong in the near-term as this material has been garnering attention in all emerging economies.

These advantages of cermets and their ability to resist high temperatures effectively are considered to be prominent drivers for the global cermet market. The lifespan of the overall manufacturing operation has increased with the effective use of cermet tools. Furthermore, with the use of cermets, main components now have a longer operational life and the accuracy in manufacturing has increased considerably. By the analysis of the above situations, the cermet market is estimated to expand with an incremental rate in the near future.

Cermet: Regional Outlook

North America and Europe have abundant natural resources and manufacturing industries, which will drive the demand for cermet materials and tools in these regions. BRICS nations are expected to contribute significantly to the global cermet market over the forecast period. Moreover, the need to manufacture perfect materials and objects will fuel growth of the global cermets market throughout the forecast period.

The cermet market is projected to grow with a high CAGR over the forecast period, due to its increasing application in all end use industries globally. Furthermore, new inventions and technologies will foster growth in the global cermet market.

Request a Complete TOC of this Report with figures: https://www.futuremarketinsights.com/toc/rep-gb-4109

Cermet Market: Market Participants

  • KYOCERA Corporation
  • Oerlikon Metco
  • NTK Cutting Tools
  • Mitsubishi Hitachi Tool Engineering, Ltd.
  • Kennametal
  • Sandvik Coromant
  • Romay Corporation
  • Taegutec Ltd.
  • Tungaloy Corporation
  • Iscar Ltd.
  • Korloy Inc.
  • Ceram Tec
  • Cermet Materials

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types and applications.

Cermet Market: segmentation

The cermet market can be segmented by product type and application.

On the basis of product type, the cermet market can be segmented as:

  • Oxide-based
  • Carbide-based
  • Nitride-based
  • Boride-based
  • Metal-based

On the basis of application, the global cermet market can be segmented into:

  • Aerospace
  • Equipment manufacturing
  • Building materials mining
  • Cutting process
  • Others (electronics, medical)

Contact Us –

Unit No: 1602-006

Jumeirah Bay 2

Plot No: JLT-PH2-X2A

Jumeirah Lakes Towers Dubai

United Arab Emirates

LinkedIn| Twitter| Blogs